Roche Boosts Outlook for Third Time as New Drugs Surge
This article is for subscribers only.
Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.
Roche Holding AG for the third time this year said sales and profit may be better than expected as its push outside cancer pays off.